SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-209020
Filing Date
2023-08-10
Accepted
2023-08-10 16:04:42
Documents
13
Period of Report
2023-08-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d480890d8k.htm   iXBRL 8-K 26430
2 EX-99.1 d480890dex991.htm EX-99.1 84616
  Complete submission text file 0001193125-23-209020.txt   248758

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ivvd-20230810.xsd EX-101.SCH 2839
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ivvd-20230810_lab.xml EX-101.LAB 18738
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ivvd-20230810_pre.xml EX-101.PRE 11700
7 EXTRACTED XBRL INSTANCE DOCUMENT d480890d8k_htm.xml XML 3457
Mailing Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451 (781) 819-0080
Invivyd, Inc. (Filer) CIK: 0001832038 (see all company filings)

IRS No.: 851403134 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40703 | Film No.: 231159209
SIC: 2836 Biological Products, (No Diagnostic Substances)